Psychedelic mushrooms have a longstanding, profound, and storied background among the many cultures that have historically used them. Today, the benefits of these powerful little fungi are being recognized in a big way.
Currently, studies into the vast and multifarious use of psychoactive mushrooms are being conducted across the United States and abroad. One such study, published in the Journal of Psychopharmacology, found that, “a single dose of psilocybin produced substantial and enduring decreases in depressed mood and anxiety along with increases in quality of life.
Additionally, the mystical and profound experiences that so many have experienced since psilocybin entered the American psychedelic lexicon in the 1960s, are now beginning to be tested and explored in mainstream medical science. The results are promising and compelling, and paint a substantiated, positive, symbiotic picture of mushrooms as a powerful healer.
Specifically, clinical trials have been, and are currently, being conducted in the United States and abroad which involve patients dealing with life-threatening cancer.
These trials mainly seek to understand the efficacy of high dose psilocybin, administered in therapeutic environments, as a tool for reducing the psychological stress and anxiety that often accompanies a life-threatening diagnosis.
The results so far have been promising. Under double-blind conditions, not only has a single, high-dose of psilocybin been shown to reduce symptoms of psychological distress among the terminal patient groups; the effects have been substantial and enduring.
Additionally, there is a growing body of research which suggests that part of why psilocybin is so effective is that it impacts neuroplasticity. That is, the brain’s ability to learn and grow and change.